Prevalence of antibodies to 2009 pandemic influenza a (H1N1) virus in German adult population in pre- and post-pandemic period

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Dudareva, Sandra ^a,b   Schweiger, Brunhilde ^b   Thamm, Michel ^b   Höhle, Michael ^b   Stark, Klaus ^b   Krause, Gérard ^b   Buda, Silke ^b   Haas, Walter ^b  

^a EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^b ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

2009 H1N1 INFLUENZA; ADULT; AGE; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CROSS REACTION; ETHNIC GROUP; FEMALE; GENDER; GERMAN; HEALTH SURVEY; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POPULATION RESEARCH; SEROPREVALENCE; ADOLESCENT; BLOOD; IMMUNOLOGY; INFLUENZA; MIDDLE AGED; VIROLOGY;

INFLUENZA A VIRUS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 79959321491     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021340     Document Type: Article

References (40)

1. CDC (2009) Update: novel influenza A (H1N1) virus infection- Mexico, March-May, 2009. MMWR 58: 585-589.
2. CDC (2009) Update: novel influenza A (H1N1) virus infections- worldwide, May 6, 2009. MMWR 58: 453-458.
3. Zarocostas J, (2009) World Health Organization declares A (H1N1) influenza pandemic. BMJ 338: b2425 doi:10.1136/bmj.b2425.
4. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360: 2605-2615.
5. Gatherer D, (2009) The 2009 H1N1 influenza outbreak in its historical context. J Clin Virol 45: 174-178.
6. Gilsdorf A, Poggensee G, (2009) Influenza A(H1N1)v in Germany: the first 10,000 cases. Euro Surveill 14: 19318.
7. Poggensee G, Gilsdorf A, Buda S, Eckmanns T, Claus H, et al. (2010) The first wave of pandemic influenza (H1N1) 2009 in Germany: from initiation to acceleration. BMC Infect Dis 10: 155.
8. Buda S, Kopke K, Haas W, (2010) [Epidemiological characteristics of the influenza pandemic (H1N1) 2009 in Germany based on the mandatory notification of cases]. BundesgesundheitsblattGesundheitsforschungGesundheitsschutz 53: 1223-1230.
9. Ikonen N, Strengell M, Kinnunen L, Osterlund P, Pirhonen J, et al. (2010) High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. Euro Surveill 15: 19478.
10. Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE Jr, et al. (2010) Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328: 357-360.
11. Zimmer SM, Burke DS, (2009) Historical perspective- Emergence of influenza A (H1N1) viruses. N Engl J Med 361: 279-285.
12. CDC (2009) Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR 58: 521-524.
13. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, et al. (2009) Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361: 1945-1952.
14. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, et al. (2010) Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 375: 1100-1108.
15. Rizzo C, Rota MC, Bella A, Alfonsi V, Declich S, et al. (2010) Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period. Vaccine 28: 3558-3562.
16. Allwinn R, Geiler J, Berger A, Cinatl J, Doerr HW, (2010) Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans? Med Microbiol Immunol 199: 117-121.
17. WHO (2010) Seroepidemiological studies of pandemic influenza A (H1N1) 2009 virus. Wkly Epidemiol Rec 85: 229-235.
18. Bandaranayake D, Huang QS, Bissielo A, Wood T, Mackereth G, et al. (2010) Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. PLoS One 5: e13211.
19. Kurth B-M, et al. (2011) DEGS- Studie zur Gesundheit Erwachsener in Deutschland (DEGS- The German Health Interview and Examination Survey for Adults). Robert Koch Institute.
20. Rowe T, Abernathy RA, Hu-Primmer J, Thompson WW, Lu X, et al. (1999) Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 37: 937-943.
21. Wagner R, (2010) Paul-Ehrlich-Institute, Division of Virology, Langen, Germany. Personal Communication.
22. Pons O, (2007) Bootstrap of means under stratified sampling. Electron J Statist 1: 381-391.
23. Tobin J, (1958) Estimation of Relationships for Limited Dependent Variables. Econometrica 26: 24-36.
24. StataCorp (2007) Statistical Software: Release 11. College Station, TX StataCorp.
25. R Development Core Team (2010) R: A language and environment for statistical computing. Vienna, Austria R Foundation for Statistical Computing.
26. Gilbert GL, Cretikos MA, Hueston L, Doukas G, O'Toole B, et al. (2010) Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter. PLoS One 5: e12562.
27. Waalen K, Kilander A, Dudman SG, Krogh GH, Aune T, et al. (2010) High prevalence of antibodies to the 2009 pandemic influenza A(H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009. Euro Surveill 15.
28. Wu JT, Ma ES, Lee CK, Chu DK, Ho PL, et al. (2010) The Infection Attack Rate and Severity of 2009 Pandemic H1N1 Influenza in Hong Kong. Clin Infect Dis 51: 1184-1191.
29. Buchholz U, Buda S, Grüber A, Schweiger B, (2009) [Association of influenza. Final report of the influenza season 2008/09]. Berlin.
30. EISS (2008) European Influenza Surveillance Scheme. Anual report 2006-2007 influenza season. Utrecht: NIVEL.
31. Meijer A, Meerhoff TJ, Meuwissen LE, van dV, Paget WJ, (2007) Epidemiological and virological assessment of influenza activity in Europe during the winter 2005-2006. Euro Surveill 12: E11-E12.
32. Meijer A, Paget WJ, Meerhoff TJ, Brown CS, Meuwissen LE, et al. (2006) Epidemiological and virological assessment of influenza activity in Europe, during the 2004-2005 winter. Euro Surveill 11: 111-118.
33. Paget WJ, Meerhoff TJ, Meijer A, (2005) Epidemiological and virological assessment of influenza activity in Europe during the 2003-2004 season. Euro Surveill 10: 107-111.
34. Skowronski DM, Hottes TS, Janjua NZ, Purych D, Sabaiduc S, et al. (2010) Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic. CMAJ.
35. Stephenson I, Das RG, Wood JM, Katz JM, (2007) Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: an international collaborative study. Vaccine 25: 4056-4063.
36. Stephenson I, Heath A, Major D, Newman RW, Hoschler K, et al. (2009) Reproducibility of serologic assays for influenza virus A (H5N1). Emerg Infect Dis 15: 1252-1259.
37. Hannoun C, Megas F, Piercy J, (2004) Immunogenicity and protective efficacy of influenza vaccination. Virus Res 103: 133-138.
38. Greenbaum JA, Kotturi MF, Kim Y, Oseroff C, Vaughan K, et al. (2009) Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci USA 106: 20365-20370.
39. McElhaney JE, Xie D, Hager WD, Barry MB, Wang Y, et al. (2006) T cell responses are better correlates of vaccine protection in the elderly. J Immunol 176: 6333-6339.
40. Boon AC, De MG, Fouchier RA, Sintnicolaas K, Osterhaus AD, et al. (2004) Preferential HLA usage in the influenza virus-specific CTL response. J Immunol 172: 4435-4443.